The ELAD Phase 2b trial of liraglutide, published in Nature Medicine, randomised 204 patients with mild to moderate disease to daily liraglutide or placebo for 52 weeks
Most importantly, having multiple options supports more personalized conversations with healthcare professionals and allows care to be tailored to individual needs, preferences and goals
We are casting a bit of a broad net in this study, said Scott Engel, vice president of biobehavioral research at Sanford Research in Fargo
For maximum effect regardless of side effect tolerance, 12mg produces the highest absolute weight loss and liver fat clearance
Dose adjustment may be required as advised by your doctor
One documented 9-week protocol showed deadlift and squat performance holding steady throughout, though this was at lower doses (0.5-1mg)